Betrouwbare informatie over goede doelen
KBS logo_Een website van.png

Meer vertrouwen

Deze database bevat betrouwbare gegevens over 6.000 Belgische verenigingen en stichtingen. We updaten de database dagelijks, op basis van informatie van officiële bronnen en de goede doelen zelf.

Steun een goed doel dat bij jou past

Wil je een goed doel steunen, financieel of als vrijwilliger? In deze database vind je meer informatie over verenigingen en goede doelen die jou nodig hebben.

Anhaive Kanker (Fonds Anhaive Kanker) Fonds op naam (Koning Boudewijnstichting)

Het Fonds Anhaive Kanker steunt onderzoek naar de klinische en moleculaire epidemiologie van kanker. Het Fonds biedt jaarlijks financiële steun aan één of twee onderzoeksprojecten ingediend door een universiteit of onderzoekscentrum in België.

Brederodestraat 21
1000 - Brussel

Telefoon (algemeen)

Wetenschappelijk onderzoek

  • Sandra Nuyts – UZ Leuven: Role of Human Papilloma Virus in Head and Neck Cancer: a new player with a potential role in epidemiology, prognosis, prevention and therapy.

    2014 - Head and neck cancers (HNSCC) are 6th most common cancers worldwide and are associated with high morbidity and mortality. They are mainly caused by alcohol/tobacco abuse but in recent years more and more HNSCC patients are identified with high risk human papillomavirus infections…


  • Sabine Tejpar – UZ Leuven: Toward a novel molecular taxonomy of colorectal cancer: miRNA based identification of disease subgroups

    2014 - Our group is a cancer research group, focusing on a particular cancer type, colorectal cancer. As part of the commitment to find better drugs to target the disease and improve patient outcomes, we perform in depth analysis of the alterations that are present…


  • Kathleen Claes – UGent: Pancreatic cancer: hope to improve prognosis through thorough analysis of DNA and RNA biomarkers for detection and therapy monitoring in liquid biopsies

    2017 - Pancreatic cancer is one of the most aggressive and lethal malignancies. Diagnosing pancreatic cancer is very challenging since early stage cancers are associated with non-specific and vague symptoms. Additionally, the current diagnostic tools have limitations and are often inconclusive. Therefore, there is a…


  • Ivan Borbath & Jean-Luc Van Laethem – Cliniques Universitaires Saint-Luc – UCL & Hôpital Erasme – ULB: Pancreatic cancer : Towards precision medicine. A collaborative, comprehensive and integrated approach in ULB-Erasme and UCL-Saint-Luc

    2017 - Pancreatic cancer is a deadly disease. In 2030, it is expected to be the second cause of cancer-related death. Currently, treatments are not based on specific abnormalities found in the individual patient with pancreatic cancer, but are based on the presence or not…



Cookie policy